he Kenneth Rainin Foundation invites applications for its Innovator Awards Program, which supports basic, translational, and clinical science that could lead to transformative discoveries for the prediction, diagnostics, treatment, and prevention of inflammatory bowel disease (IBD). Grants of up to $150,000 for projects by individual researchers and up to $300,000 for collaborative projects involving multiple investigators will be awarded.
Researchers worldwide working in any scientific discipline are eligible for funding. Those who typically receive funding hold advanced degrees (MD, PhD, or the equivalent) and academic positions at universities, medical centers, or research institutions. Nonprofits must not be classified as a private foundation under section 509(a)(3) of the Internal Revenue Code. For-profit institutions must demonstrate that their proposed project furthers the Rainin Foundation’s charitable mission of promoting scientific and medical research.
Letters of inquiry are due September 30, 2024, at 5:00 p.m. PT and upon review, selected applicants will be invited to submit a full proposal by February 3, 2025, at 5:00 p.m. PT.